Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IHC 2021 | CEFALY device in migraine: unanswered questions

Deena Kuruvilla • 9 Sep 2021
IHC 2021
Headache

Deena Kuruvilla, MD, Westport Headache Institute, Westport, CT, discusses the unanswered questions regarding the use of the CEFALY device in migraine treatment. In particular, Dr Kuruvilla highlights the importance of pushing research to understand the mechanisms behind the device and how the pain of migraine is being modulated. This interview took place during the International Headache Congress 2021.

Disclosures

Consultant: Cefaly, Neurolief, Theranica, Nowwhat media, KX advisors
Speakers Bureau: Abbvie/Allergan, Amgen/Novartis, Lilly, American Headache Society, Biohaven, CME meeting
Advisory Board: Abbvie/Allergan, Lilly, Theranica, Amgen/Novartis
Editor, Associate Editor: Healthline
Author: WebMD/Medscape, Healthline

More from Deena Kuruvilla

4:50
Patient perspective of complementary and integrative medicine for migraine treatment
Deena Kuruvilla • 9 Sep 2021
1:34
Non-pharmacologic devices in migraine prevention & treatment
Deena Kuruvilla • 9 Sep 2021
1:30
The CEFALY device: an external trigeminal nerve stimulator
Deena Kuruvilla • 9 Sep 2021
5:12
Updates on the Phase III TEAM study of CEFALY for migraine treatment
Deena Kuruvilla • 9 Sep 2021

Related Videos

1:01
Challenging cases in medication overuse headache
Morris Levin • 22 Mar 2024
1:53
Navigating complex cases of medication overuse headache
Alan Rapoport • 22 Mar 2024
2:14
Switching acute treatments in medication overuse headache
Alan Rapoport • 22 Mar 2024
3:35
Promising targets in headache research: PACAP
Alan Rapoport • 22 Mar 2024
The content of VJNeurology is intended for healthcare professionals